HER2-positive Advanced Breast Cancer
Oncology
Prevalence
287.0 / 100K
Incidence
128.0 / 100K/yr
0 drugs in development·0 companies·3 clinical trials
Frequently asked questions
How many clinical trials target HER2-positive Advanced Breast Cancer?
There are 3 clinical trials targeting HER2-positive Advanced Breast Cancer tracked by BioSniper.
What is the prevalence of HER2-positive Advanced Breast Cancer?
The estimated prevalence of HER2-positive Advanced Breast Cancer is approximately 287.0 per 100,000 population.
Deep-dive into HER2-positive Advanced Breast Cancer
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis